CellRapeutics™ Leukopak from Lung Cancer Donor (XS-0426-XU248)

Name: CellRapeutics™ Leukopak from Lung Cancer Donor
SKU: XS-0426-XU248
Rating: 5 (1 reviews)

Online Inquiry Datasheet

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Sourced from donors with biopsy-confirmed Lung Cancer, this Leukopak provides a comprehensive reservoir of immune cells conditioned by the pulmonary tumor microenvironment. The collection includes circulating tumor-reactive T cells, myeloid-derived suppressor cells, and regulatory T cells that reflect the systemic immunosuppressive state. This product is optimized for the discovery of neoantigen-specific TCRs and the study of peripheral immune evasion mechanisms in thoracic oncology.

Specific Inquiry

Add to Cart

Donor Information

Product Name
CellRapeutics™ Leukopak from Lung Cancer Donor

Cat. No.
XS-0426-XU248

Donor Age
Senior

Donor Health
Donors are diagnosed with pulmonary malignancy. The immune environment is characterized by systemic responses to tumor-derived factors and potential signs of respiratory-targeted immune exhaustion.

Ethnicity
Diverse backgrounds available.

Anticoagulant
Acid Citrate Dextrose, optimized to preserve the exhaustion markers and functional plasticity of tumor-infiltrating-like lymphocytes.

Additional Donor Information
Each lot features a Leukopak from donors with confirmed pulmonary malignancy. Profiles include histological subtype, tumor stage, and prior treatment history for immuno-oncology research.

Clinical Profile
Histological type, clinical stage, and history of chemotherapy, radiotherapy, or immunotherapy.

Additional Information

Medication History
Available upon request. Documentation of chemotherapy, radiation, targeted therapies, and history of immune checkpoint inhibitor therapy.

Formulation
Cryopreserved or Fresh options available.

Cell Purity
>90%

Cell Viability
>90%

Mycoplasma Testing
Negative

Sterility Testing
Negative

Genetic Stability Testing
The donor cells maintain their native genetic profile, exhibiting no karyotypic abnormalities or chromosomal instabilities typically associated with prolonged ex vivo expansion.

Application
Drug Discovery, Immuno-oncology Research

Research Use Only
RUO

Quality Control
Each product batch is strictly validated for high cellular viability, specific immune cell counts, and pathogen-free safety, ensuring consistent clinical phenotypes and ethical compliance for advanced immunological research.

Storage
Store fresh Leukopaks at 2°C to 8°C for immediate use, cryopreserved samples must be kept in liquid nitrogen vapor phase below -150°C.

Shiping
Dry Ice

Handling Notes
Process fresh cells within 48 hours or perform rapid thawing of cryovials in a 37°C water bath followed by gradual dilution to maximize recovery.

Warnings
Treat as potentially biohazardous human-derived material and handle strictly under BSL-2 guidelines using appropriate personal protective equipment.

Size
Full Bag, Half Bag

Keywords
CellRapeutics™ Leukopak from Lung Cancer Donor, Leukopak, Lung Cancer

Case Studies

Customer Reviews and Q&As

There are currently no customer reviews or questions for CellRapeutics™ Leukopak from Lung Cancer Donor (XS-0426-XU248). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.